PPAR Agonists and Metabolic Syndrome: An Established Role?

Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated receptors (PPARs) are involved in the metabolic regulation of lipid and lipoprotein levels, i.e., triglycerides (TGs), blood gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Botta, Margherita, Audano, Matteo, Sahebkar, Amirhossein, Sirtori, Cesare R., Mitro, Nico, Ruscica, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979533/
https://www.ncbi.nlm.nih.gov/pubmed/29662003
http://dx.doi.org/10.3390/ijms19041197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979533/
https://www.ncbi.nlm.nih.gov/pubmed/29662003
http://dx.doi.org/10.3390/ijms19041197

Ejemplares similares